“…Normal physiologic distribution of In-111 octreotide includes faint visualization of thyroid, pituitary gland and marked increased uptake in the liver, spleen, kidneys and bladder. Although rarely encountered, false-positive studies have been reported due to increased activity at nonmalignant pathologies such as Paget’s disease, parathyroid adenoma, cholecystitis, thrombus, abscess, infection, pulmonary fibrosis, pleural plaques and uterine myomas ( 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ). Only a few cases in the literature have reported increased In-111 octreotide activity in the gallbladder ( 10 , 11 , 12 , 13 , 14 ).…”